Efficacy of individualized homeopathy as an adjunct to standard of care of COVID-19: A randomized, single-blind, placebo-controlled study

https://doi.org/10.1016/j.ctcp.2022.101602Get rights and content
Under a Creative Commons license
open access

Highlights

  • A randomized, placebo-controlled trial of adjunct homeopathy with standard of care for COVID-19 was conducted on 300 patients.

  • Primary outcome on total symptom score measured over 10 days decreased significantly favoring Standard of care + Homeopathy.

  • Recovery was earlier in Standard of care + Homeopathy group by 02 days showing the added benefits of homeopathy.

  • Resolution of fever was 20 h earlier in Standard of care + Homeopathy.

  • Arsenicum album, Bryonia alba and Phosphorus were the most frequently prescribed medicines.

Cited by (0)